drugset / Trial / NCT04006340
Empirical vs Tailored Therapy for H. Pylori Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
We aimed to compare the efficacy of genotypic resistance-guided tailored therapy vs empirical therapy for eradication of Helicobacter pylori (H. pylori) infection in randomized controlled trials.
Timeline
- Start
- 2019-01-04
- Primary completion
- 2019-08-31
- Completion
- 2019-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Bismuth Potassium Citrate | Unknown | 300 mg | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Metronidazole | Small molecule | 500 mg | — |
| Subject | Tetracycline | Unknown | 500 mg | — |
| Background | Esomeprazole | Small molecule | 40 mg | — |